Genetic Testing Company 23andMe Going Public At $3.5 Billion Valuation, Focus On More Therapeutics
While personal genetic testing as entertainment slowed as a revenue source in recent years, 23andMe has doubled down on its therapeutic programs.
Yes, It Is Worth Making A Federal Case Over Angelina Jolie’s Boobs
Angelina Jolie took action to address her cancer risk. If the Supreme Court gets its act together, more women can follow her example.
Managing Partners are Navigating the AI Inflection Point.
New executive research from Ari Kaplan explores how law firm leaders are responding to changing client expectations, evolving economics, talent transformation, and AI governance.